Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2

Cross-Neutralization Potential of Native Human Papillomavirus N-Terminal L2 Epitopes

(2011) Michael J. Conway et al.   PLoS One

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67

(2011) Zigui Chen et al.   PLoS One

A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2

(2011) Ebenezer Tumban et al.   PLoS One

Vaccines to Prevent Infections by Oncoviruses

(2010) John T. Schiller et al.   Annual Review of Microbiology

Whole-Genome Sequence Analysis of Human Papillomavirus Type 18 from Infected Thai Women

(2010) Woradee Lurchachaiwong et al.   INTERVIROLOGY

Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection

(2010) Subhashini Jagu et al.   VACCINE

The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies

(2010) Ivonne Rubio et al.   VIROLOGY

HPV Vaccines: Preclinical Development

(2009) Lutz Gissmann   ARCHIVES OF MEDICAL RESEARCH

Abundance of Multiple High-Risk Human Papillomavirus (HPV) Infections Found in Cervical Cells Analyzed by Use of an Ultrasensitive HPV Genotyping Assay

(2009) Markus Schmitt et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines

(2009) C. Schellenbacher et al.   JOURNAL OF VIROLOGY

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET

High-throughput detection and multiplex identification of cell contaminations

(2009) M. Schmitt et al.   NUCLEIC ACIDS RESEARCH

The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding

(2009) R. C. Kines et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20–38) peptide displayed on bacterial thioredoxin

(2009) Ivonne Rubio et al.   VACCINE

Nuclear location of minor capsid protein L2 is required for expression of a reporter plasmid packaged in HPV51 pseudovirions

(2009) Kazunari Kondo et al.   VIROLOGY

Human Papillomavirus Infection in Ulaanbaatar, Mongolia: A Population-Based Study

(2008) B. Dondog et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Homogeneous Amplification of Genital Human Alpha Papillomaviruses by PCR Using Novel Broad-Spectrum GP5+ and GP6+ Primers

(2008) M. Schmitt et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Evolutionary Dynamics of Variant Genomes of Human Papillomavirus Types 18, 45, and 97

(2008) Z. Chen et al.   JOURNAL OF VIROLOGY

Mechanisms of Human Papillomavirus Type 16 Neutralization by L2 Cross-Neutralizing and L1 Type-Specific Antibodies

(2008) P. M. Day et al.   JOURNAL OF VIROLOGY